William Noss

William Noss, CPA, CGMA, is a finance professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently, William serves as Vice President of Finance at Dragonfly Therapeutics, Inc., starting in November 2023. Previously, William held the position of Chief Financial Officer at Pulmotect, Inc. from 2021 to December 2023. William's career includes key roles such as Executive Director of Finance and Controller at Harmony Biosciences, Head of Finance and Controller at Aevi Genomic Medicine, International Controller at Telerx, and Manager of Global Consolidation at ViroPharma Incorporated. William began the professional journey at KPMG in the Audit Department, supervising financial statement audits and gaining experience with US GAAP and IFRS. William earned a Bachelor’s degree in Accounting from King's College in 2006.